Recursion Pharmaceuticals has an exciting approach to developing therapies. The company recently reported positive phase 2 ...

Investorideas.com, a go-to investing platform covering cannabis stocks releases an industry snapshot looking at the battle ...

Sana Biotechnology Inc (SANA) stock saw a modest uptick, ending the day at $4.62 which represents a slight increase of $0.33 or 7.69% from the prior close of $4.29. The stock opened at $4.47 and ...

Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label ...

In the RG Kar Medical College & Hospital rape-murder case, the CBI Special Crime Branch has submitted a petition requesting ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Healthcare ETFs hold the potential for higher returns, diversification, and exposure to stably growing companies. Therefore, ...

Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...

We recently published a list of 7 Best ASX Stocks To Invest In Right Now. In this article, we are going to take a look at ...

Kineta will be trading under the symbol “KANT” on OTC PinkKineta will continue to pursue strategic alternatives as previously announcedTuHURA ...

Earlier this week, we took a look at Argenica Therapeutics (ASX:AGN), a brain injury-focused clinical-stage biotech ...